Department of Veterans Affairs: Tennessee Valley Healthcare System (VISN 9), Nashville, TN, USA.
Curr Osteoporos Rep. 2011 Jun;9(2):89-95. doi: 10.1007/s11914-011-0052-5.
Tumors such as breast, lung, and prostate frequently metastasize to bone, where they can cause intractable pain and increase the risk of fracture in patients. When tumor cells metastasize to bone, they interact with the microenvironment to promote bone destruction primarily through the secretion of osteolytic factors by the tumor cells and the subsequent release of growth factors from the bone. Our recent data suggest that the differential rigidity of the mineralized bone microenvironment relative to that of soft tissue regulates the expression of osteolytic factors by the tumor cells. The concept that matrix rigidity regulates tumor growth is well established in solid breast tumors, where increased rigidity stimulates tumor cell invasion and metastasis. Our studies have indicated that a transforming growth factor-β (TGF-β) and Rho-associated kinase (ROCK)-dependent mechanism is involved in the response of metastatic tumor cells to the rigid mineralized bone matrix. In this review, we will discuss the interactions between ROCK and TGF-β signaling, as well as potential new therapies that target these pathways.
肿瘤如乳腺癌、肺癌和前列腺癌经常转移到骨骼,在那里它们会引起难以控制的疼痛,并增加患者骨折的风险。当肿瘤细胞转移到骨骼时,它们与微环境相互作用,主要通过肿瘤细胞分泌溶骨性因子和随后从骨骼释放生长因子来促进骨破坏。我们最近的数据表明,矿化骨微环境的相对刚性与软组织的相对刚性调节肿瘤细胞溶骨性因子的表达。基质刚性调节实体乳腺癌中肿瘤生长的概念已经得到很好的确立,其中刚性增加刺激肿瘤细胞侵袭和转移。我们的研究表明,转化生长因子-β(TGF-β)和 Rho 相关激酶(ROCK)依赖性机制参与了转移性肿瘤细胞对刚性矿化骨基质的反应。在这篇综述中,我们将讨论 ROCK 和 TGF-β信号之间的相互作用,以及针对这些途径的潜在新疗法。